Novo Nordisk ( NVO +1.68%) was once the top player in the weight loss drug market. The company's medicine, Wegovy, ...

Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of ...

Eli Lilly won approval for its tirzepatide under the names Mounjaro for type 2 diabetes and Zepbound for weight loss -- in ...

Amazon Pharmacy said on Friday it now offers Novo Nordisk's Wegovy weight-loss pill through insurance plans as well as ...

In the last week of December, while most of the U.S. was still in holiday mode, Novo Nordisk’s plant in North Carolina was ...

Mike Doustdar, Novo Nordisk president and CEO, joins 'Mad Money' host Jim Cramer to talk the success of GLP-1, pricing for ...

Amazon Pharmacy said on Friday it now offers Novo Nordisk's Wegovy pill through insurance plans as well as through a cash-pay ...

Novo Nordisk is reshaping its strategy around obesity and diabetes, CEO Maziar Mike Doustdar said at the 44 th Annual J.P.

Investing.com -- UBS raised its 12-month price target for Novo Nordisk to 390 from 295 Danish crowns, citing valuation ...

Drugmaker Novo Nordisk manufactures Wegovy. Moore told FOX Business that clinical trials show the pill delivers similar ...

A new Wegovy pill is now available nationwide, giving adults a daily tablet option instead of weekly shots for weight loss ...

With prices starting at $149 for cash-paying patients, the new Wegovy pill undercuts much of the current market.